Ischemic stroke
Conditions
Interventions
None listed
Sponsors
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences
signpost corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)The enrolled subjects in JSTARS study (2)The subjects from whom the informed consent was obtained
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Genetic markers responsible to the high risk of stroke recurrence , efficacy of HMG-CoA inhibitor, and appearance of cognitive impairment | — |
Countries
Japan
Contacts
Public ContactTomohisa Nezu
Hiroshima University Graduate School of Biomedical Sciences Department of Clinical Neuroscience and Therapeutics
Outcome results
None listed